Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,561 | 344 | 96.2% |
| Education | $220.27 | 3 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $564.80 | 34 | $0 (2019) |
| Novo Nordisk Inc | $543.87 | 27 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $501.53 | 35 | $0 (2019) |
| Amgen Inc. | $476.23 | 27 | $0 (2019) |
| Lilly USA, LLC | $366.74 | 21 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $359.47 | 25 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $281.69 | 16 | $0 (2019) |
| PFIZER INC. | $279.43 | 13 | $0 (2018) |
| Allergan Inc. | $252.85 | 17 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $240.34 | 16 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $110.78 | 2 | Astellas Pharma US Inc ($89.00) |
| 2019 | $833.76 | 52 | Novo Nordisk Inc ($149.80) |
| 2018 | $1,974 | 121 | Amgen Inc. ($194.95) |
| 2017 | $2,863 | 172 | SANOFI-AVENTIS U.S. LLC ($386.32) |
All Payment Transactions
347 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/28/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/14/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $89.00 | General |
| 10/10/2019 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 07/30/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Diabetes | ||||||
| 07/29/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/23/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $11.94 | General |
| Category: Cardiovascular | ||||||
| 07/22/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: UROLOGY | ||||||
| 07/17/2019 | Allergan Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/10/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: DIABETES | ||||||
| 07/09/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/08/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Central Nervous System (CNS) | ||||||
| 06/27/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $12.91 | General |
| Category: Cardiovascular | ||||||
| 06/26/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: DIABETES | ||||||
| 06/25/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Bone Health | ||||||
| 06/20/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Neuroscience | ||||||
| 06/19/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Diabetes | ||||||
| 06/13/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Diabetes | ||||||
| 06/13/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Hypertriglyceridemia | ||||||
| 06/11/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Diabetes | ||||||
| 06/10/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/06/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: VACCINE | ||||||
| 06/05/2019 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT (Drug), FLUZONE QUADRIVALENT, FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: VACCINES | ||||||
| 06/04/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $35.32 | General |
| Category: Cardiovascular | ||||||
| 05/16/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/14/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Central Nervous System (CNS) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 794 | 1,232 | $180,164 | $76,903 |
| 2022 | 9 | 761 | 1,330 | $185,869 | $74,592 |
| 2021 | 12 | 1,316 | 2,030 | $246,357 | $85,722 |
| 2020 | 18 | 1,920 | 3,109 | $361,882 | $153,558 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 212 | 448 | $124,342 | $39,741 | 32.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 171 | 171 | $29,241 | $22,898 | 78.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 64 | 64 | $4,972 | $4,604 | 92.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 59 | $11,623 | $4,048 | 34.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 194 | 380 | $5,700 | $3,111 | 54.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 69 | 70 | $3,150 | $2,275 | 72.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 12 | $492.00 | $134.75 | 27.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 27 | 28 | $644.00 | $92.48 | 14.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 223 | 492 | $132,159 | $45,056 | 34.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 145 | 145 | $24,795 | $20,116 | 81.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 58 | $10,768 | $3,585 | 33.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $6,051 | $1,638 | 27.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 20 | 22 | $1,510 | $1,487 | 98.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 231 | 505 | $7,575 | $1,477 | 19.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 25 | 27 | $1,215 | $862.23 | 71.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 18 | 18 | $738.00 | $214.19 | 29.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 36 | 46 | $1,058 | $158.66 | 15.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 420 | 780 | $173,270 | $44,857 | 25.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 160 | 160 | $27,360 | $22,721 | 83.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 73 | 87 | $13,050 | $4,018 | 30.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 55 | 55 | $3,575 | $3,575 | 100.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $5,488 | $2,182 | 39.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 12 | 12 | $2,304 | $2,170 | 94.2% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 15 | 16 | $4,128 | $2,165 | 52.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 412 | 732 | $10,980 | $2,156 | 19.6% |
About Dr. Douglas Pinto, MD
Dr. Douglas Pinto, MD is a Internal Medicine healthcare provider based in Catonsville, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790745750.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Pinto, MD has received a total of $5,781 in payments from pharmaceutical and medical device companies, with $110.78 received in 2021. These payments were reported across 347 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,561).
As a Medicare-enrolled provider, Pinto has provided services to 4,791 Medicare beneficiaries, totaling 7,701 services with total Medicare billing of $390,777. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Catonsville, MD
- Active Since 03/24/2006
- Last Updated 04/13/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1790745750
Products in Payments
- Prolia (Biological) $299.34
- TOUJEO (Drug) $293.55
- Trintellix (Drug) $287.81
- TRULICITY (Drug) $265.81
- ENTRESTO (Drug) $240.34
- FARXIGA (Drug) $212.86
- JANUVIA (Drug) $202.80
- TRADJENTA (Drug) $201.07
- ZOSTAVAX (Biological) $194.73
- SOLIQUA (Drug) $193.43
- Victoza (Drug) $169.97
- JARDIANCE (Drug) $167.52
- Tresiba (Drug) $160.61
- Ozempic (Drug) $148.26
- ANORO (Drug) $138.32
- XARELTO (Drug) $132.78
- Truvada (Drug) $119.00
- NIOX VERO DEVICE (Device) $110.00
- BEVESPI AEROSPHERE (Drug) $104.95
- VIBERZI (Drug) $97.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Catonsville
Charles Moore, M.d, M.D
Internal Medicine — Payments: $10,315
Dr. Robert Ammlung, M.d, M.D
Internal Medicine — Payments: $8,640
Dr. Scott Poulton, M.d, M.D
Internal Medicine — Payments: $8,200
Dr. Benjamin Lee, M.d, M.D
Internal Medicine — Payments: $6,688
Dr. Debra Curtis, M.d, M.D
Internal Medicine — Payments: $6,181
Dr. Gregory Levickas, Md, MD
Internal Medicine — Payments: $4,697